The role of death receptor ligands in shaping tumor microenvironment.
about
The Evolving Role of Immune Checkpoint Inhibitors in Cancer TreatmentVaccines versus immunotherapy: overview of approaches in deciding between optionsCommon gene variants in the tumor necrosis factor (TNF) and TNF receptor superfamilies and NF-kB transcription factors and non-Hodgkin lymphoma riskCytoplasmic overexpression of CD95L in esophageal adenocarcinoma cells overcomes resistance to CD95-mediated apoptosis.Molecular targets for selective killing of TRAIL-resistant leukemic cells.T cell-tumor interaction directs the development of immunotherapies in head and neck cancer.Fas receptor (CD95) & Fas ligand (CD178) expression in patients with tobacco-related intraoral squamous cell carcinoma.Prostaglandin E2 stimulates Fas ligand expression via the EP1 receptor in colon cancer cells.Immune responses to malignancies.Spontaneous apoptosis of tumor-specific tetramer+ CD8+ T lymphocytes in the peripheral circulation of patients with head and neck cancerRetinoic acid morpholine amide (RAMA) inhibits expression of Fas ligand through EP1 receptor in colon cancer cells.Prognostic Role of Programmed Death Ligand-1 Expression in Breast Cancer: A Systematic Review and Meta-Analysis.Molecular Markers in the Pathogenesis of Cholangiocarcinoma: Potential for Early Detection and Selection of Appropriate Treatment.Polymorphisms of the FAS and FASL genes and risk of breast cancer.Myoepithelial cells from pleomorphic adenoma are not influenced by tumor conditioned media from breast ductal adenocarcinoma and melanoma cells: An in vitro study.Novel TBL1XR1, EPHA7 and SLFN12 mutations in a Sezary syndrome patient discovered by whole exome sequencing.
P2860
Q27022789-30DF09D6-F3D6-47CE-8E7D-9C590B9F20C3Q28085434-2F734DCB-683B-469D-B4EA-9B3BBF19B70AQ33434511-640F4399-3296-4A07-8157-CD18A6E30B1FQ33841936-81C910BD-7AA9-40BA-A7D9-F26F8FBD3854Q33891400-AFF4F45B-01D1-4530-B64A-F376A3FF74E6Q34475726-340D54C5-B2F3-4402-8EE3-E93AABE9EE96Q35210153-B931BB6F-E73D-411E-B385-1A7536CD5961Q36858103-9F62A6C3-1490-4938-B093-90CE92E12603Q37040501-C25D4789-E484-4D75-9D98-2F6B4E7F7FEDQ37040545-433ABD8B-E7EC-47C0-B28F-CC4C399ECEC9Q38849334-6645F42C-5374-4F83-BE83-E9A1B033EFA3Q38898344-317C4F6A-79F8-4C71-A58E-2CDDF0BBDFCDQ39033749-C749F654-771D-4860-B777-D9F21D6650A9Q41811141-62F408D9-F176-4013-B089-47342CF11499Q43042566-41982F01-76FA-460A-84CA-CA5D6864A1FFQ53059753-4BD7AD91-BB4F-45B0-AEA1-649162447DB8
P2860
The role of death receptor ligands in shaping tumor microenvironment.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
The role of death receptor ligands in shaping tumor microenvironment.
@ast
The role of death receptor ligands in shaping tumor microenvironment.
@en
type
label
The role of death receptor ligands in shaping tumor microenvironment.
@ast
The role of death receptor ligands in shaping tumor microenvironment.
@en
prefLabel
The role of death receptor ligands in shaping tumor microenvironment.
@ast
The role of death receptor ligands in shaping tumor microenvironment.
@en
P2860
P1476
The role of death receptor ligands in shaping tumor microenvironment.
@en
P2093
Theresa L Whiteside
P2860
P356
10.1080/08820130600991893
P577
2007-01-01T00:00:00Z